EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 23 filers reported holding EVOKE PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,000 | 0.0% | 490 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -99.8% | 490 | -99.8% | 0.00% | – |
| Q1 2018 | $416,000 | -8.0% | 200,000 | 0.0% | 0.00% | – |
| Q4 2017 | $452,000 | – | 200,000 | +99900.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 200 | -86.7% | 0.00% | – |
| Q1 2017 | $4,000 | -20.0% | 1,500 | +41.2% | 0.00% | – |
| Q2 2015 | $5,000 | +150.0% | 1,062 | +164.2% | 0.00% | – |
| Q4 2014 | $2,000 | – | 402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
| Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
| Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
| STATE STREET CORP | 72,800 | $41,000 | 0.00% |
| MORGAN STANLEY | 9,606 | $5,000 | 0.00% |